Novo Nordisk A/S - share repurchase programme

Summary by AI BETAClose X

Novo Nordisk confirmed continuation of a DKK 15 billion share repurchase programme over 12 months from 4 February 2026 and a Safe Harbour tranche of up to DKK 11,200,000,010.45 (6 May 2026–1 February 2027). Since 9 November additional purchases brought accumulated Safe Harbour repurchases to 28,975,000 B shares valued at DKK 8,318,073,280, and since 4 February 2026 Novo has repurchased 43,734,179 B shares at an average DKK 277.08 for DKK 12,118,073,269. Novo now holds 57,645,131 treasury B shares, representing 1.3% of share capital.

Disclaimer*

UK 100

Latest directors dealings